{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:13:21Z","timestamp":1788178401393,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["Grant Number: SLJ201906"],"award-info":[{"award-number":["Grant Number: SLJ201906"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of the Boxi Cultivation Program of the First Affiliated Hospital of Soochow University","award":["BXQN2025004"],"award-info":[{"award-number":["BXQN2025004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01439-4","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:13:15Z","timestamp":1788174795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CD276 promotes lipid metabolic reprogramming and regulates ferroptosis in clear cell renal cell carcinoma by upregulating FASN expression via SREBP1"],"prefix":"10.1007","volume":"39","author":[{"given":"ZhiYu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YanHang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChuanAo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8818-7891","authenticated-orcid":false,"given":"Jun","family":"OuYang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"1439_CR1","unstructured":"Bahadoram S, et al. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022;39(3):2022-vol3."},{"issue":"8","key":"1439_CR2","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.3390\/ijms18081774","volume":"18","author":"A Mehdi","year":"2017","unstructured":"Mehdi A, Riazalhosseini Y. Epigenome aberrations: emerging driving factors of the clear cell renal cell carcinoma. Int J Mol Sci. 2017;18(8):1774.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1439_CR3","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jama.2024.12848","volume":"332","author":"TL Rose","year":"2024","unstructured":"Rose TL, Kim WY. Renal cell carcinoma: a review. JAMA. 2024;332(12):1001\u201310.","journal-title":"JAMA"},{"issue":"5","key":"1439_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.11329","volume":"4","author":"NH Chakiryan","year":"2021","unstructured":"Chakiryan NH, et al. Real-world survival outcomes associated with first-line immunotherapy, targeted therapy, and combination therapy for metastatic clear cell renal cell carcinoma. JAMA Netw Open. 2021;4(5):e2111329.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"1439_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00432-024-05663-z","volume":"150","author":"A Soares","year":"2024","unstructured":"Soares A, et al. Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update. J Cancer Res Clin Oncol. 2024;150(4):183.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"1439_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13046-023-02742-w","volume":"42","author":"Y Xu","year":"2023","unstructured":"Xu Y, et al. TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma. J Exp Clin Cancer Res. 2023;42(1):159.","journal-title":"J Exp Clin Cancer Res"},{"issue":"28","key":"1439_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202504532","volume":"12","author":"Z Ye","year":"2025","unstructured":"Ye Z, et al. A feedback loop between fatty acid metabolism and epigenetics in clear cell renal carcinoma. Adv Sci (Weinh). 2025;12(28):e04532.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"1439_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41420-025-02479-9","volume":"11","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, et al. The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma. Cell Death Discov. 2025;11(1):186.","journal-title":"Cell Death Discov"},{"issue":"1","key":"1439_CR9","doi-asserted-by":"publisher","first-page":"C283","DOI":"10.1152\/ajpcell.00066.2025","volume":"329","author":"W Li","year":"2025","unstructured":"Li W, et al. Biological and metabolomic insights into RACGAP1-mediated growth and progression of clear cell renal cell carcinoma. Am J Physiol Cell Physiol. 2025;329(1):C283\u201397.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1439_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2025.101188","volume":"66","author":"Y Chi","year":"2025","unstructured":"Chi Y, et al. Deletion of the transcription factor ATF4 in a model of clear cell renal cell carcinoma. Neoplasia. 2025;66:101188.","journal-title":"Neoplasia"},{"issue":"6","key":"1439_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2025.119989","volume":"1872","author":"Y Su","year":"2025","unstructured":"Su Y, et al. Salinomycin inhibits SREBP1 to sensitize ferroptosis and ameliorate sorafenib resistance in clear cell renal cell carcinoma. Biochim Biophys Acta Mol Cell Res. 2025;1872(6):119989.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"1439_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1545339","volume":"16","author":"D Sun","year":"2025","unstructured":"Sun D, et al. Lipid metabolism in ferroptosis: mechanistic insights and therapeutic potential. Front Immunol. 2025;16:1545339.","journal-title":"Front Immunol"},{"issue":"7","key":"1439_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41419-023-05930-w","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z, et al. Ferroptosis as a potential target for cancer therapy. Cell Death Dis. 2023;14(7):460.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1439_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41392-020-00216-5","volume":"5","author":"D Li","year":"2020","unstructured":"Li D, Li Y. The interaction between ferroptosis and lipid metabolism in cancer. Signal Transduct Target Ther. 2020;5(1):108.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1439_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-024-02122-8","volume":"24","author":"Y Wang","year":"2025","unstructured":"Wang Y, et al. CircASAP1 induces renal clear cell carcinoma ferroptosis by binding to HNRNPC and thereby regulating GPX4. Mol Cancer. 2025;24(1):1.","journal-title":"Mol Cancer"},{"key":"1439_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.09.014","volume":"522","author":"Y Lu","year":"2021","unstructured":"Lu Y, et al. KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma. Cancer Lett. 2021;522:1\u201313.","journal-title":"Cancer Lett"},{"key":"1439_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111421","volume":"124","author":"Z Chen","year":"2024","unstructured":"Chen Z, et al. TRIB3 knockdown increases the sensitivity of clear cell renal cell carcinoma to sunitinib by inducing ferroptosis. Cell Signal. 2024;124:111421.","journal-title":"Cell Signal"},{"issue":"2","key":"1439_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2023.10.011","volume":"31","author":"J Rodencal","year":"2024","unstructured":"Rodencal J, et al. Sensitization of cancer cells to ferroptosis coincident with cell cycle arrest. Cell Chem Biol. 2024;31(2):234\u201348 e13.","journal-title":"Cell Chem Biol"},{"key":"1439_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1586759","volume":"16","author":"S Zhao","year":"2025","unstructured":"Zhao S, Zhang H, Shang G. Research progress of B7-H3 in malignant tumors. Front Immunol. 2025;16:1586759.","journal-title":"Front Immunol"},{"issue":"1","key":"1439_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2516294","volume":"14","author":"T Fang","year":"2025","unstructured":"Fang T, et al. PARP inhibitors accumulate B7-H3 on fibroblasts via blocking autophagic flux to potentiate immune evasion in ovarian cancer. Oncoimmunology. 2025;14(1):2516294.","journal-title":"Oncoimmunology"},{"issue":"5","key":"1439_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167771","volume":"1871","author":"H Liu","year":"2025","unstructured":"Liu H, et al. B7-H3-mediated deubiquitination stabilizing CYP1B1 expression promotes chemotherapy resistance in colorectal cancer. Biochim Biophys Acta Mol Basis Dis. 2025;1871(5):167771.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"1439_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13000-025-01645-y","volume":"20","author":"P Fontao","year":"2025","unstructured":"Fontao P, et al. High B7\u2013H3 protein expression in medulloblastoma is associated with metastasis and unfavorable patient outcomes. Diagn Pathol. 2025;20(1):49.","journal-title":"Diagn Pathol"},{"issue":"4","key":"1439_CR23","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.4049\/jimmunol.172.4.2352","volume":"172","author":"P Steinberger","year":"2004","unstructured":"Steinberger P, et al. Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J Immunol. 2004;172(4):2352\u20139.","journal-title":"J Immunol"},{"key":"1439_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.701006","volume":"12","author":"WT Zhou","year":"2021","unstructured":"Zhou WT, Jin WL. B7\u2013H3\/CD276: an emerging cancer immunotherapy. Front Immunol. 2021;12:701006.","journal-title":"Front Immunol"},{"issue":"9","key":"1439_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024751","volume":"6","author":"J Sun","year":"2011","unstructured":"Sun J, et al. Origination of new immunological functions in the costimulatory molecule B7\u2013H3: the role of exon duplication in evolution of the immune system. PLoS ONE. 2011;6(9):e24751.","journal-title":"PLoS ONE"},{"key":"1439_CR26","first-page":"0549","volume":"8","author":"S Meng","year":"2025","unstructured":"Meng S, et al. PRMT5-mediated ALKBH5 methylation promotes colorectal cancer immune evasion via increasing CD276 expression. Research (Wash D C). 2025;8:0549.","journal-title":"Research (Wash D C)"},{"issue":"1","key":"1439_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1186\/s12885-025-13973-9","volume":"25","author":"S Liu","year":"2025","unstructured":"Liu S, et al. Targeting CD276: a promising strategy for CAR-NK cell immunotherapy in human oral tongue squamous cell carcinoma. BMC Cancer. 2025;25(1):593.","journal-title":"BMC Cancer"},{"key":"1439_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1408051","volume":"14","author":"S Wu","year":"2024","unstructured":"Wu S, et al. Non-immune functions of B7-H3: bridging tumor cells and the tumor vasculature. Front Oncol. 2024;14:1408051.","journal-title":"Front Oncol"},{"issue":"1","key":"1439_CR29","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1038\/s41467-024-51096-0","volume":"15","author":"C Zhang","year":"2024","unstructured":"Zhang C, et al. ITGB6 modulates resistance to anti-CD276 therapy in head and neck cancer by promoting PF4(+) macrophage infiltration. Nat Commun. 2024;15(1):7077.","journal-title":"Nat Commun"},{"issue":"3","key":"1439_CR30","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.21037\/jgo-24-384","volume":"15","author":"C Hu","year":"2024","unstructured":"Hu C, et al. B7\u2013H3 enhances colorectal cancer progression by regulating HB-EGF via HIF-1alpha. J Gastrointest Oncol. 2024;15(3):1035\u201349.","journal-title":"J Gastrointest Oncol"},{"issue":"11","key":"1439_CR31","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1111\/cas.15944","volume":"114","author":"H Jin","year":"2023","unstructured":"Jin H, et al. B7H3 increases ferroptosis resistance by inhibiting cholesterol metabolism in colorectal cancer. Cancer Sci. 2023;114(11):4225\u201336.","journal-title":"Cancer Sci"},{"key":"1439_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.912190","volume":"13","author":"Y Dong","year":"2022","unstructured":"Dong Y, et al. A prognostic signature for clear cell renal cell carcinoma based on ferroptosis-related lncRNAs and immune checkpoints. Front Genet. 2022;13:912190.","journal-title":"Front Genet"},{"key":"1439_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111381","volume":"124","author":"R Cao","year":"2024","unstructured":"Cao R, et al. Pharmacological inhibition of SREBP1 suppresses pancreatic cancer growth via inducing GPX4-mediated ferroptosis. Cell Signal. 2024;124:111381.","journal-title":"Cell Signal"},{"issue":"4","key":"1439_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010924","volume":"13","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, et al. Targeting B7\u2013H3 inhibition-induced activation of fatty acid synthesis boosts anti-B7-H3 immunotherapy in triple-negative breast cancer. J Immunother Cancer. 2025;13(4):e010924.","journal-title":"J Immunother Cancer"},{"issue":"7","key":"1439_CR35","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.7150\/thno.70194","volume":"12","author":"Y Xuan","year":"2022","unstructured":"Xuan Y, et al. SCD1\/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells. Theranostics. 2022;12(7):3534\u201352.","journal-title":"Theranostics"},{"issue":"7","key":"1439_CR36","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41419-024-06848-7","volume":"15","author":"YN Zheng","year":"2024","unstructured":"Zheng YN, et al. Selective PI3Kdelta inhibitor TYM-3-98 suppresses AKT\/mTOR\/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer. Cell Death Dis. 2024;15(7):474.","journal-title":"Cell Death Dis"},{"issue":"4","key":"1439_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.04.022","volume":"11","author":"Y He","year":"2024","unstructured":"He Y, et al. The roles and mechanisms of SREBP1 in cancer development and drug response. Genes Dis. 2024;11(4):100987.","journal-title":"Genes Dis"},{"issue":"13","key":"1439_CR38","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202400721R","volume":"38","author":"X Wang","year":"2024","unstructured":"Wang X, et al. SREBP-1-mediated lipogenesis confers resistance to ferroptosis and improves endothelial injury. FASEB J. 2024;38(13):e23806.","journal-title":"FASEB J"},{"issue":"3","key":"1439_CR39","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41419-023-05697-0","volume":"14","author":"Q Cheng","year":"2023","unstructured":"Cheng Q, et al. Correction: semaphorin 5A suppresses ferroptosis through activation of PI3K-AKT-mTOR signaling in rheumatoid arthritis. Cell Death Dis. 2023;14(3):196.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1439_CR40","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s12672-025-03116-8","volume":"16","author":"J Zhu","year":"2025","unstructured":"Zhu J, et al. Integrative analysis of cholesterol homeostasis reveals prognostic subtypes and immune features in clear cell renal cell carcinoma. Discov Oncol. 2025;16(1):1261.","journal-title":"Discov Oncol"},{"key":"1439_CR41","doi-asserted-by":"publisher","first-page":"4647115","DOI":"10.1155\/humu\/4647115","volume":"2025","author":"D Zhang","year":"2025","unstructured":"Zhang D, et al. Integrated genomic and functional characterization of palmitoylation in clear cell renal cell carcinoma. Hum Mutat. 2025;2025:4647115.","journal-title":"Hum Mutat"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01439-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01439-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01439-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:13:19Z","timestamp":1788174799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01439-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1439"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01439-4","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of The First Affiliated Hospital of Soochow University and written informed consent was provided by all patients prior to the study start. All procedures were performed in accordance with the ethical standards of the Institutional Review Board and The Declaration of Helsinki, and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were complied with the ARRIVE guidelines and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The experiments were approved by the Institutional Animal Care and Use Committee of The First Affiliated Hospital of Soochow University (Approval No. 797, 2025).","order":3,"name":"Ethics","label":"Ethical statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"132"}}